Last reviewed · How we verify

NCT05191407

Fear and Anxiety Level in Dental Patients During the COVID-19 Pandemic

Completed Last updated 13 January 2022
What this trial tests

trial in Fear in 301 participants. Completed in 23 October 2020.

Timeline
23 September 2020
Primary endpoint
23 October 2020
23 October 2020

Quick facts

Lead sponsorZeliha Aytekin
StatusCompleted
Study typeOBSERVATIONAL
Enrollment301
Start date23 September 2020
Primary completion23 October 2020
Estimated completion23 October 2020
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Zeliha Aytekin

Who can join

Adults 18 to 75, any sex, with Fear or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Psychological support may be needed to help patients in the face of emotional disturbances that may be associated with the outbreak and to help them accomplish their fear and anxiety. Due to the increasing fear of COVID-19 transmission during the pandemic, patients may develop treatment avoidance behavior in dental practices. If the fear and anxiety levels of the patients can be determined, it may be easy to offer special approaches to them.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fear

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05191407.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing